| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 08/23/1995 | EP0667859A1 Molecule labelling using 2-hydraninopyridine derivatives |
| 08/22/1995 | US5444153 Plasminogen activator inhibitor which has been altered to eliminate a protease sensitive site |
| 08/22/1995 | US5444069 Imidazo-pyridine angiotensin II antagonists used to treat memory loss |
| 08/22/1995 | US5443953 Genetic engineering; diagnosis, therapy |
| 08/22/1995 | US5443816 Peptide-metal ion pharmaceutical preparation and method |
| 08/22/1995 | US5443815 Technetium-99m labeled peptides for imaging |
| 08/22/1995 | US5443813 A biocompatible apoferritin the blood protein ferritin which has iron content removed to fill with radioactive uranium; drug delivery |
| 08/17/1995 | WO1995021868A1 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 08/17/1995 | WO1995021845A1 Texaphyrin metal complexes having improved functionalization |
| 08/17/1995 | WO1995021601A2 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
| 08/17/1995 | CA2185683A1 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 08/17/1995 | CA2182960A1 Texaphyrin metal complexes having improved functionalization |
| 08/16/1995 | EP0666859A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
| 08/16/1995 | EP0666736A1 Stabilization of fluorocarbon emulsions. |
| 08/15/1995 | US5442043 Peptide conjugate |
| 08/15/1995 | US5441871 Monoclonal antibody reactive to human leukemia and lymphoma cells and methods of using same for diagnosis and treatment |
| 08/15/1995 | US5441745 Marking tumors in the body; biodegradable |
| 08/15/1995 | US5441722 Short synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-[C3 H3 ]-4[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide and related non radioactive compounds |
| 08/15/1995 | CA1336739C Diphosphonate-derivatized macromolecules |
| 08/10/1995 | WO1995021251A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions |
| 08/10/1995 | WO1995020981A1 Agent for marking bodily tissues |
| 08/10/1995 | WO1995018830A3 Inhibitors of human plasmin derived from the kunitz domains |
| 08/10/1995 | DE4403789A1 Mittel zur visuellen Markierung von Körpergewebe Means for visually marking body tissue |
| 08/10/1995 | CA2182686A1 Agent for marking bodily tissues |
| 08/10/1995 | CA2182685A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions |
| 08/09/1995 | EP0665853A1 Multimeric polyvalent antithrombotic agents |
| 08/09/1995 | EP0665729A1 Biocompatible polymers containing diagnostic or therapeutic moieties |
| 08/08/1995 | US5439795 Cystine residue linked to glycine residue at the end of carboxy terminus of peptide; animal growth regulator |
| 08/08/1995 | US5439668 Heterocyclic chelating agents |
| 08/08/1995 | US5439666 Iodinated neuroprobe for mapping monoamine reuptake sites |
| 08/08/1995 | US5439665 Detection and treatment of infectious and inflammatory lesions |
| 08/08/1995 | US5439570 Water soluble texaphyrin metal complexes for singlet oxygen production |
| 08/03/1995 | WO1995020603A1 Inhibitors of serine proteases, bearing a chelating group |
| 08/03/1995 | WO1995020320A1 Self-assembling multimeric nucleic acid constructs |
| 08/03/1995 | CA2179889A1 Inhibitors of serine proteases, bearing a chelating group |
| 08/02/1995 | EP0664819A1 Chelating polymers. |
| 08/02/1995 | EP0664713A1 Therapeutic and diagnostic imaging compositions and methods |
| 08/02/1995 | EP0664710A1 NON-PEPTIDYL MOIETY-CONJUGATED CD4-GAMMA2 AND CD4-IgG2 IMMUNOCONJUGATES, AND USES THEREOF |
| 08/01/1995 | US5438071 Stable porfimer sodium compositions and methods for their manufacture |
| 08/01/1995 | CA1336494C Emulsions of highly fluorinated organic compounds |
| 07/27/1995 | WO1995019841A1 Particulate material |
| 07/27/1995 | WO1995019791A1 Radiolabeled annexins |
| 07/27/1995 | WO1995009848A3 Polyazacycloalkanes as dichelants |
| 07/27/1995 | CA2181254A1 Particulate material |
| 07/26/1995 | EP0663900A1 Metal-oxime chelates for use as radiopharmaceutical agents |
| 07/25/1995 | US5436352 Metal radionuclide chelating compounds for improved chelation kinetics |
| 07/25/1995 | US5435990 Chelate-antibody complexes, treatment and diagnosis of cancer, tetraazacyclododecane compounds |
| 07/25/1995 | US5435989 Tumors, phospholipid micelles |
| 07/25/1995 | CA1336438C Cationic complexes of technetium-99m |
| 07/25/1995 | CA1336437C Ligands and cationic complexes thereof with technetium 99-m |
| 07/20/1995 | WO1995019338A1 Ligands and metal complexes thereof |
| 07/20/1995 | WO1995019187A1 Biological targeting agents |
| 07/20/1995 | WO1995019184A1 Polymeric microparticles containing agents for imaging |
| 07/20/1995 | WO1995019167A1 Therapeutic treatment for inhibiting vascular restenosis |
| 07/20/1995 | CA2181035A1 Therapeutic treatment for inhibiting vascular restenosis |
| 07/20/1995 | CA2179990A1 Biological targeting agents |
| 07/20/1995 | CA2156605A1 Ligands and metal complexes thereof |
| 07/19/1995 | EP0662972A1 3-,8-substituted deuteroporphyrine derivatives, pharmaceuticals containing them and methods of producing them |
| 07/19/1995 | EP0662842A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 07/18/1995 | US5434287 Bifunctional DTPA-type ligand |
| 07/18/1995 | US5434076 Tumor-specific, cell surface-binding monoclonal antibodies |
| 07/18/1995 | US5434050 Labelled β-amyloid peptide and methods of screening for Alzheimer's disease |
| 07/18/1995 | US5433940 Synthetic molecules mimic action of hirudin by binding to both the low affinity anion-binding exosite and the catalytic site of thrombin |
| 07/13/1995 | WO1995018832A1 New polyaminocarboxylate chelators |
| 07/13/1995 | WO1995018830A2 Inhibitors of human plasmin derived from the kunitz domains |
| 07/13/1995 | WO1995018668A1 Process for separating carrier-free radionuclides from target liquids, its use and arrangement therefor |
| 07/13/1995 | DE19500428A1 Sepn. of carrier-free radionuclides from target liquids |
| 07/13/1995 | CA2180662A1 New polyaminocarboxylate chelators |
| 07/12/1995 | EP0662148A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 07/12/1995 | EP0662137A1 Gene transcription and ionizing radiation: methods and compositions |
| 07/12/1995 | EP0662075A1 Prostaglandin analog for treating osteoporosis |
| 07/12/1995 | EP0662005A1 Microparticle preparations made from biodegradable copolymers |
| 07/12/1995 | EP0662001A1 Multifunctional ligands for potential use in the design of therapeutic or diagnostic radiopharmaceutical imaging agents |
| 07/12/1995 | EP0390798B1 Method and compositions relating to regression-associated antigens |
| 07/11/1995 | US5432171 Water soluble texaphyrin metal complexes for viral deactivation |
| 07/11/1995 | US5432058 Method for measuring human cholesterol absorption using metabolically stable isotopes |
| 07/11/1995 | US5431900 Ester-substituted diaminedithiols and radiolabeled complexes thereof |
| 07/11/1995 | US5431897 Diagnosis, monoclonal antibodies |
| 07/11/1995 | CA1336272C Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
| 07/06/1995 | WO1995014491A3 Metal-ion chelates with acidic saccharides and glycosaminoglycans |
| 07/05/1995 | EP0661267A1 Chelating agent for attaching metal ions to proteins |
| 07/05/1995 | EP0660722A1 Stabilized therapeutic radiopharmaceutical complexes |
| 07/05/1995 | EP0521954B1 Technecium complexes of thioethers |
| 07/05/1995 | CN1104646A Peptides |
| 07/04/1995 | US5429814 Molecular sieve-enclosed transition and rare earth metal ions as contrast agents for the gastrointestinal tract |
| 07/04/1995 | CA1336167C Stabilized radiopharmaceutical compositions |
| 07/04/1995 | CA1336166C Further improvements relating to drug delivery systems |
| 07/04/1995 | CA1336162C Method for myocardial infarct risk assessment |
| 06/29/1995 | WO1995017419A1 Metal chelators |
| 06/29/1995 | CA2179379A1 Metal chelators |
| 06/28/1995 | EP0659764A2 Peptides modified by the phosphine group for marking with 99mTC and 186-188Re or paramagnetic agents |
| 06/28/1995 | EP0470965B1 Preparation of rhenium phosphonate therapeutic agents |
| 06/28/1995 | EP0401302B1 Method of preparing a metal-radionuclide-labelled protein |
| 06/28/1995 | CN1104217A Peptides having T cell helper activity |
| 06/27/1995 | US5428155 PH controlled sulfomethylation of 1,4,7,10-tetraazacyclododecane; displacement with sodium cyanide; hydrolysis to symmetrical acetic acid side groups |
| 06/27/1995 | US5428154 Complexes of functionalized tetraazacyclododecane chelates with bismuth, lead, ytriium, actinium, or lanthanide metal ions |
| 06/27/1995 | US5428139 Anticarcinogenic agents |
| 06/27/1995 | US5428025 Method of treating inflammation by blocking ELAM-1 receptor sites |
| 06/27/1995 | US5427767 Particles having crosslinked coatings of natural or synthetic mucopolysaccharides, for contrast in nuclear magnetic resonance imaging |
| 06/27/1995 | US5427766 Radiolabeled steroids for use in radiochemical-guided surgery |